Infectious diarrhea in autologous stem cell transplantation: high prevalence of coccidia in a South American center
- PMID: 30057986
- PMCID: PMC6001927
- DOI: 10.1016/j.htct.2017.10.002
Infectious diarrhea in autologous stem cell transplantation: high prevalence of coccidia in a South American center
Abstract
Background: Diarrhea is frequently seen in autologous stem cell transplantation. Although toxicity related to conditioning is the most common cause, infectious pathogens can play a distinctive role particularly in certain regions and environments.
Methods: The role of enteropathogens was investigated in 47 patients submitted to autologous stem cell transplantation at a Brazilian center between May 2011 and May 2013. All patients who presented with diarrhea consented to stool sample analysis to identify the etiological agents including coccidia, Strongyloides sp., Clostridium difficile and other pathogenic bacteria.
Results: Thirty-nine patients (83%) had diarrhea, among whom seven (17.5%) presented with coccidia, three (7.5%) with Candida sp., one (2.5%) with C. difficile, and one (2.5%) with Giardia lamblia. There was a tendency toward a higher incidence of diarrhea in older patients (p-value = 0.09) and those who received conditioning with lomustine, etoposide, cytarabine, and melphalan (p-value = 0.083). Furthermore, the number of days of neutropenia was higher in patients with diarrhea (p-value = 0.06).
Conclusions: The high frequency of diarrhea caused by coccidia shows the importance of investigating and correctly identifying etiological agents and highlights the possible varieties of intestinal infections in patients who undergo autologous stem cell transplantation.
Keywords: Coccidia; Diarrhea; Etiological agent; Stem cell transplant.
References
-
- Bobak D., Arfons L.M., Creger R.J., Lazarus H.M. Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplant. 2008;42(11):705–713. - PubMed
-
- Arango J.I., Restrepo A., Schneider D.L., Callander N.S., Ochoa-Bayona J.L., Restrepo M.I. Incidence of Clostridium difficile-associated diarrhea before and after autologous blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant. 2006;37(5):517–521. - PubMed
-
- Anderson K.O., Giralt S.A., Mendoza T.R., Brown J.O., Neumann J.L., Mobley G.M. Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant. 2007;39(12):759–766. - PubMed
-
- Musher D.M., Aslam S. Treatment of Clostridium difficile colitis in the critical care setting. Crit Care Clin. 2008;24(2):279–291. - PubMed
-
- Nomura K., Fujimoto Y., Yamashita M., Morimoto Y., Ohshiro M., Sato K. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents. Scand J Gastroenterol. 2009;44(1):74–78. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
